ECSP961824A - FORM III ACID CALCIUM SALT CRYSTALLINE [R- (R *, R *) - 2- (4 FLUOROFENIL) - B, G- DIHIDROXI-5- (1 METHYLETHYL) - 3- FENIL - 4 - [(FENILAMINO) CARBONYL] - 1H -PIRROL - 1- HEPTANOIC (2.1) - Google Patents

FORM III ACID CALCIUM SALT CRYSTALLINE [R- (R *, R *) - 2- (4 FLUOROFENIL) - B, G- DIHIDROXI-5- (1 METHYLETHYL) - 3- FENIL - 4 - [(FENILAMINO) CARBONYL] - 1H -PIRROL - 1- HEPTANOIC (2.1)

Info

Publication number
ECSP961824A
ECSP961824A ECSP961824A ECSP961824A EC SP961824 A ECSP961824 A EC SP961824A EC SP961824 A ECSP961824 A EC SP961824A EC SP961824 A ECSP961824 A EC SP961824A
Authority
EC
Ecuador
Prior art keywords
heptanoic
methylethyl
carbonyl
calcium salt
form iii
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Ann T Mckenzie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP961824 priority Critical patent/ECSP961824A/en
Publication of ECSP961824A publication Critical patent/ECSP961824A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una forma cristalina nueva de sal de calcio de ácido [R-(R*, R*)-2-(4-fluorofenil)-ß, 8-dihidroxi-5-(1-metiletil)-3-fenil-4-[(fenilamino)carbonil]-1H-pirrol-1-heptanoico (2:1) denominada Forma III caracterizada por la difracción de cristales finos de rayos X y/o resonancia magnética nuclear descripta, así como los métodos para la elaboración y composición farmacéutica de la misma, que es útil como agente para tratar la hiperlipidemia e hipercolesterolemia.A new crystalline form of the calcium salt of [R- (R *, R *) - 2- (4-fluorophenyl) -ß, 8-dihydroxy-5- (1-methylethyl) -3-phenyl-4- [ (phenylamino) carbonyl] -1H-pyrrole-1-heptanoic (2: 1) called Form III characterized by the X-ray fine crystal diffraction and / or nuclear magnetic resonance described, as well as the methods for the preparation and pharmaceutical composition of the same, which is useful as an agent to treat hyperlipidemia and hypercholesterolemia.

ECSP961824 1996-07-17 1996-07-17 FORM III ACID CALCIUM SALT CRYSTALLINE [R- (R *, R *) - 2- (4 FLUOROFENIL) - B, G- DIHIDROXI-5- (1 METHYLETHYL) - 3- FENIL - 4 - [(FENILAMINO) CARBONYL] - 1H -PIRROL - 1- HEPTANOIC (2.1) ECSP961824A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP961824 ECSP961824A (en) 1996-07-17 1996-07-17 FORM III ACID CALCIUM SALT CRYSTALLINE [R- (R *, R *) - 2- (4 FLUOROFENIL) - B, G- DIHIDROXI-5- (1 METHYLETHYL) - 3- FENIL - 4 - [(FENILAMINO) CARBONYL] - 1H -PIRROL - 1- HEPTANOIC (2.1)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP961824 ECSP961824A (en) 1996-07-17 1996-07-17 FORM III ACID CALCIUM SALT CRYSTALLINE [R- (R *, R *) - 2- (4 FLUOROFENIL) - B, G- DIHIDROXI-5- (1 METHYLETHYL) - 3- FENIL - 4 - [(FENILAMINO) CARBONYL] - 1H -PIRROL - 1- HEPTANOIC (2.1)

Publications (1)

Publication Number Publication Date
ECSP961824A true ECSP961824A (en) 1997-12-09

Family

ID=42042554

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP961824 ECSP961824A (en) 1996-07-17 1996-07-17 FORM III ACID CALCIUM SALT CRYSTALLINE [R- (R *, R *) - 2- (4 FLUOROFENIL) - B, G- DIHIDROXI-5- (1 METHYLETHYL) - 3- FENIL - 4 - [(FENILAMINO) CARBONYL] - 1H -PIRROL - 1- HEPTANOIC (2.1)

Country Status (1)

Country Link
EC (1) ECSP961824A (en)

Similar Documents

Publication Publication Date Title
AR003459A1 (en) FORM III CRYSTALLINE ATORVASTATINE AND ITS HYDRATES AND PHARMACEUTICAL COMPOSITIONS WITH THE SAME.
MY118398A (en) FORM 111 CRYSTALLINE [R-(R*,R*)]-2-(4-FLUOROPHENYL)-ß, S- DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO) CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID CALCIUM SALT (2:1).
GEP20053546B (en) Crystalline Forms of 'R-(R*,R*)!-2-(4- Fluorophenyl)-Beta, Delta-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-'Phenylamino) Carbonyl!-1H-Pyrrole-1-Heptanoic Acid Calcium Salt (2:1) (Atorvastatin)
KR910002794A (en) [R- (R *, R *)]-2- (4-fluorophenyl) β, σ-dihydroxy-5-1- (1-methylethyl) -3-phenyl-4 [phenylamino) car Bonyl] -1H-pyrrole-1heptanoic acid, its lactone form and salts
AR004122A1 (en) PROCEDURE FOR THE PREPARATION OF A COMPOUND OF DIHALOAZOLOPIRIMIDINES AND A PROCEDURE FOR THE PREPARATION OF AN INTERMEDIARY OF SUCH PROCEDURE
DK0839132T5 (en) Process for the preparation of amorphous [R- (R *, R *)] - 2- (4-fluorophenyl) -beta, delta-dihydroxy-5- (1-methylethyl) -3-phenyl-4 - [(phenylamino) carbonyl ] -1H-pyrrole-1-heptanoic acid calcium salt (2: 1)
BR0113200A (en) Therapeutic combination
ECSP961824A (en) FORM III ACID CALCIUM SALT CRYSTALLINE [R- (R *, R *) - 2- (4 FLUOROFENIL) - B, G- DIHIDROXI-5- (1 METHYLETHYL) - 3- FENIL - 4 - [(FENILAMINO) CARBONYL] - 1H -PIRROL - 1- HEPTANOIC (2.1)
AR045654A1 (en) CRYSTAL ACID FORMS R- (R *, R *) - 2- (4- FLUOROPHENYL) -, DIHYDROXI - 5- (1- METHYLETHYL) - 3- PHENYL- 4- (PHENYLAMINE) - CARBONIL- 1H- PIRROL-1 - HEPTANOIC
DE69616358D1 (en) CRYSTALLINE FORM III OF THE HEMI CALCIUM SALTS OF [R- (R *, R *)] - 2- (4-FLUORPHENYL) -BETA-DELTA-DIHYDROXY-5- (1-METHYLETHYL) -3-PHENYL-4 - [( PHENYLAMINO) CARBONYL] -1H-PYRROL-1-HEPTANIC ACID (ATORVASTATIN)
ECSP961823A (en) CRYSTALLINE ACID [R- (R *, R *)] - 2- (4- FLUOROFENIL) -B, 8 -DIHIDROXI- 5- (1- METHYLETHYL) - 3 - FENIL- 4- [(FENILAMINO) CARBONIL] - 1H - PIRROL - 1- HEPTANOIC CALCIUM SALT (2.1)
UY27608A1 (en) HYDRATED CRYSTAL FORMS OF ATORVASTATIN FORM II AND FORM IV.
TH13382B (en) Lll form crystals of calcium salt (2
TH32710A (en) Lll form crystals of calcium salt (2